AI assistant
Azelis Group NV — Major Shareholding Notification 2026
May 5, 2026
3909_mrq_2026-05-05_e2a65a55-1760-466b-a6ef-43960a998d36.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Azelis news release
REGULATED INFORMATION
5 May 2026
Transparency notification from UBS Group AG
Antwerp (Belgium), 5 May 2026 – 17:45 CET – In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV announces that on 1 May 2026, it has received a transparency notification from UBS Group AG.
1. Summary of the notification
UBS Group AG reported in its notification dated 1 May 2026, that on 29 April 2026, following a disposal of equivalent financial instruments, UBS Group AG (taking into account the holding of all its affiliates), decreased its holdings in financial instruments and crossed downward the threshold of 3.00% in Azelis Group NV.
On 29 April 2026, UBS Group AG (taking into account the holding of all its affiliates) owned 643,290 shares with voting rights, representing 0.26% of the total number of shares issued by the company (243,921,719), versus 279,984 shares representing 0.11% in its previous notification dated 25 November 2025, as well as 6,932,000 equivalent financial instruments, representing 2.84% of the voting rights issued by the company, versus 9,265,170 equivalent financial instruments, representing 3.80% in its previous notification dated 25 November 2025.
2. Content of the notification
Reason for the notification
Acquisition or disposal of voting securities or voting rights
Notification by
A parent undertaking or a controlling person
Persons subject to the notification requirement
| Name | Address (for legal entities) |
|---|---|
| UBS Group AG | Bahnhofstrasse 45, 8001 Zürich |
Date on which the threshold is crossed
azelis
Innovation through formulation
Azelis news release
29 April 2026
Threshold that is crossed (in %)
3%
Denominator
243,921,719
Notified Details
| A) Voting rights | Previous notification | After the transaction | |||
|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | |||
| Holders of voting rights | Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities | |
| UBS Group AG | 0 | 0 | 0 | 0.00% | 0.00% |
| UBS AG | 0 | 272,130 | 0 | 0.11% | 0.00% |
| UBS Europe SE | 20,000 | 0 | 0 | 0.00% | 0.00% |
| UBS Asset Management (Europe) S.A. | 80,518 | 96,614 | 0 | 0.04% | 0.00% |
| UBS Asset Management Life Limited | 8,128 | 8,128 | 0 | 0.00% | 0.00% |
| UBS Fund Management (Ireland) Ltd. | 72 | 0 | 0 | 0.00% | 0.00% |
| UBS Fund Management (Switzerland) AG | 171,266 | 241,418 | 0 | 0.10% | 0.00% |
| UBS Securities LLC | 0 | 25,000 | 0 | 0.01% | 0.00% |
| Subtotal | 279,984 | 643,290 | 0.26% | ||
| TOTAL | 643,290 | 0 | 0.26% | 0.00% |
B) Equivalent financial instruments
After the transaction
azelis
Innovation through formulation
Azelis news release
| Holders of equivalent financial instruments | Type of financial instrument | Expiration date | Exercise period or date | # of voting rights that may be acquired if the instrument is exercised | % of voting rights | Settlement |
|---|---|---|---|---|---|---|
| UBS AG | Long Call Option | 17/12/2027 | 177,000 | 0.07% | physical | |
| UBS AG | Long Call Option | 17/03/2028 | 61,500 | 0.03% | physical | |
| UBS AG | Equity Swaps | 28/03/2028 | 1,092 | 0.00% | cash | |
| UBS Switzerland AG | Right of use over shares | At any time | 2,068,479 | 0.85% | physical | |
| UBS AG | Right of use over shares | At any time | 124,735 | 0.05% | physical | |
| UBS AG | Right to Recall of Lent shares | At any time | 602,517 | 0.25% | physical | |
| UBS Switzerland AG | Right to Recall of Lent shares | At any time | 3,890,000 | 1.59% | physical | |
| UBS AG | Right to Substitute shares delivered as collaterals | At any time | 6,677 | 0.00% | physical | |
| TOTAL | 6,932,000 | 2.84% | ||||
| TOTAL (A & B) | # of voting rights | % of voting rights | ||||
| --- | --- | --- | --- | |||
| CALCULATE | 7,575,290 | 3.11% |
Chain of controlled undertakings through which the holding is effectively held, if applicable
Please see full chain of control attached.
Additional information
The disclosure obligation arose due to the indirect holdings in financial instrument of UBS Group AG in voting rights of Azelis Group NV, held directly by controlled undertakings, going below 3% on 29 April 2026.
3. Further information
The full transparency notification as well as this press release can be consulted on the Azelis Group NV's website.
azelis
Innovation through formulation
Azelis news release
END
Contact information:
Azelis
[email protected]
About Azelis
Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry, present in 64 countries across the globe with over 4,100 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a comprehensive portfolio of complementary products to more than 65,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.1 billion (2025). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.
Across our extensive network of more than 70 application laboratories, our award-winning teams develop innovative and sustainable formulations and provide technical guidance throughout the product development process. We combine global market reach with a local footprint to offer reliable, integrated, and unique digital services to local customers and attractive business opportunities to principals. Recognised for our sustainability leadership, we are committed to responsible growth that positively impacts people, communities and the planet. Through the application of science and deep market expertise, we act as catalysts for innovation, enabling our customers to win and our principals to grow.
Innovation through formulation.
www.azelis.com
azelis
Innovation through formulation
Azelis news release
Attachment – Chain of control
| 11. Information in relation to the person subject to the notification obligation – organizational chart |
|---|
| UBS Group AG |
| UBS AG |
| UBS Switzerland AG |
| - |
| UBS Group AG |
| UBS AG |
| UBS Europe SE |
| - |
| UBS Group AG |
| UBS AG |
| UBS Asset Management AG |
| UBS Asset Management (Europe) S.A. |
| - |
| UBS Group AG |
| UBS AG |
| UBS Asset Management AG |
| UBS Asset Management Holding (No. 2) Ltd |
| UBS Asset Management Holding Ltd |
| UBS Asset Management Life Ltd |
| - |
| UBS Group AG |
| UBS AG |
| UBS Fund Management (Ireland) Ltd. |
| - |
| UBS Group AG |
| UBS AG |
| UBS Asset Management AG |
| UBS Asset Management Switzerland AG |
| UBS Fund Management (Switzerland) AG |
| - |
| UBS Group AG |
| UBS AG |
| UBS Americas Holding LLC |
| UBS Americas Inc. |
| UBS Securities LLC |
azelis
Innovation through formulation
Azelis news release